Factors associated with mortality from systemic lupus erythematosus;Factores asociados a la mortalidad del lupus eritematoso sistémico

Seminarios de la Fundacion Espanola de Reumatologia

Volumn 9, Issue 4, 2008, Pages 219-234

  Rúa Figueroa, Iñigo ^a   Erausquin, Celia ^a  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Lupus; Mortality; Risk factors

Indexed keywords

CHOLESTEROL; CYCLOPHOSPHAMIDE;

ANEMIA; ANTIPHOSPHOLIPID SYNDROME; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL CARE; MORTALITY; REVIEW; SOCIAL CARE; SUN EXPOSURE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; UREMIA;

EID: 57449104366     PISSN: 15773566     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1577-3566(08)75215-1     Document Type: Review

References (90)

1. Kumar A, Malaviya AN, Singh RR, et al. Survival in patients with systemic lupus erythematosus in India. Rheumatol Int.1992;12:107-9.
2. Walsh SJ, Algert C, Gregorio DI, et al. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol. 1995;22:1663-8.
3. Urowitz MB, Gladman DD, Abu-Shakra M, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheum. 1997;24:1061-5.
4. Bernatsky S, Clarke A, Gladman DD, et al. Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus. 2006;15:835-9.
5. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic Lupus erythematosus. Medicine. 2006;85:147-56.
6. Chun BC, Bae SC. Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea. Lupus. 2005;14:635-8.
7. Moss KE, Ioannou Y, Sultan SM, et al. Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades. Ann Rheum Dis. 2002;61:409-13.
8. Jacobsen S, Petersen J, Ullman S, et al. Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol. 1999;28:75-80.
9. Manger K, Manger B, Repp R, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis. 2002;61:1065-70.
10. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2550-7.
11. Uramoto KM, Michet CJ Jr, Thumboo J, et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999;42:46-50.
12. Alamanos Y, Voulgari PV, Papassava M, et al. Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort. Rheumatology (Oxford). 2003;42:1122-3.
13. Ståhl-Hallengren C, Jönsen A, Nived O, et al. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J Rheumatol. 2000;27:685-91.
14. Calvo-Alén J, Alarcón GS, Campbell R Jr, et al. Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology (Oxford). 2005;44:1186-9.
15. Mok C, Mak A, Chu W, et al. Long-term survival of Southern Chinese patients with systemic lupus erythematosus: A prospective study of all age-groups. Medicine (Balt). 2005;84:218-24.
16. Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol. 1995;22:1265-70.
17. Ward MM, Pyun E, Studensky S. Long-term survival in systemic lupus erythematosus. Arthritis Rheum. 1995;38:274-83.
18. Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 1990;33:37-48.
19. Bertoli AM, Alarcón GS, Calvo-Alén J, et al; LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Arthritis Rheum. 2006;54:1580-7.
20. Andrade RM, Alarcón GS, Fernández M, et al. Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort; LUMINA Study Group. Arthritis Rheum. 2007;56:622-3.
21. Garcia MA, Marcos JC, Marcos AI, et al. Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients. Lupus. 2005;14:938-46.
22. Doria A, Iaccarino L, Ghirardello A, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med. 2006;119:700-6.
23. Buján S, Ordi-Ros J, Paredes J, et al. Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients. Ann Rheum Dis. 2003;62:859-65.
24. Kiss E, Regéczy N, Szegedi G. Systemic lupus erythematosus survival in Hungary. Results from a single centre. Clin Exp Rheumatol. 1999;17:171-7.
25. Molina JF, Drenkard C, Molina J, et al. Systemic lupus erythematosus in males: A study of 107 Latin American patients. Medicine (Balt). 1996;75:124-30.
26. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982;25:601-11.
27. Fernández M, Alarcón GS, Calvo-Alén J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007;57:576-84.
28. Krishnan E, Hubert HB. Ethnicity and mortality from systemic lupus erythematosus in the US. Ann Rheum Dis. 2006;65:1500-5.
29. Johnson SR, Urowitz MB, Ibañez D, et al. Ethnic variation in disease patterns and health outcomes in systemic lupus erythematosus. J Rheumatol. 2006;33:1990-5.
30. Blanco FJ, De la Mata J, López-Fernández JI, et al. Light, immunofluorescence and electron microscopy renal biopsy findings as predictors of mortality in eighty-five Spanish patients with systemic lupus erythematosus. Br J Rheumatol. 1994;33:260-6.
31. Alarcón GS, McGwin G Jr, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum. 2001;45:191-202.
32. Studenski S, Allen NB, Caldwell DS, et al. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum. 1987;30:1326-32.
33. Pons-Estel BA, Catoggio LJ, Cardiel MH, et al; Grupo Latinoamericano de Estudio del Lupus. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics". Medicine (Balt). 2004;83:1-17.
34. Massardo L, Martínez ME, Jacobelli S, et al. Survival of Chilean patients with systemic lupus erythematosus. Semin Arthritis Rheum. 1994;24:1-11.
35. Ward MM. Education level and mortality in systemic lupus erythematosus (SLE): evidence of underascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthritis Rheum. 2004;51:616-24.
36. Mayor AM, Vilá LM, de la Cruz M, et al. Impact of managed care on clinical outcome of systemic lupus erythematosus in Puerto Rico. J Clin Rheumatol. 2003;9:25-32.
37. Mok CC, Lee KW, Ho CT, et al. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford). 2000;39:399-406.
38. Pistiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum. 1991;21:55-64.
39. Jacobsen S, Petersen J, Ullman S, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol. 1998;17:478-84.
40. Drenkard C, Villa AR, Alarcón-Segovia D, et al. Influence of antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J Rheumatol. 1994;21:6.
41. Wallace DJ, Podell T, Weiner J, et al. Systemic lupus erythematosus survival patterns. Experience with 609 patients. JAMA. 1981;245:934-8.
42. Esdaile JM, Abrahamowicz M, MacKenzie T, et al. The time-dependence of long-term prediction in lupus nephritis. Arthritis Rheum. 1994;37:359-68.
43. Bellomio V, Spindler A, Lucero E, et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus. 2000;9:377-81.
44. McLaughlin JR, Bombardier C, Farewell VT, et al. Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables. Arthritis Rheum. 1994;37:559-67.
45. Nosset HC, Henzen-Logmans SC, Vroom TM, et al. Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum. 1990;33:970-7.
46. Sibley JT, Olszynski WP, Decoteau WE, et al. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol. 1992;19:47-52.
47. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Intern Med. 1996;156:1337-44.
48. Jönsen A, Bengtsson AA, Nived O, et al. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxford). 2002;41:1308-12.
49. Reshetniak TM, Alekberova ZS, Kotel'nikova GP, et al. Survival and prognostic factors of death risk in antiphospholipid syndrome: results of 8-year follow-up. Ter Arkh. 2003;75:46-51.
50. Ruiz-Irastorza G, Egurbide MV, Ugalde J, et al. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med. 2004;164:77-82.
51. Yu YW, Liu ZR, Xie D, et al. Clinical significance of antineutrophil cytoplasmic antibodies in patients with lupus nephritis. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26:833-6.
52. Hitchon CA, Peschken CA. Sm antibodies increase risk of death in systemic lupus erythematosus. Lupus. 2007;16:186-94.
53. Nossent JC. Course and prognostic value of Systemic Lupus Erythematosus Disease Activity Index in black Caribbean patients. Semin Arthritis Rheum. 1993;23:16-21.
54. Becker-Merok A, Nossent HC. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. J Rheumatol. 2006;33:1570-7.
55. Cook RJ, Gladman DD, Pericak D, et al. Prediction of short term mortality in systemic lupus erythematosus. J Rheumatol. 2000;27:1892-5.
56. Stoll T, Sutcliffe N, Mach J, et al. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus - a 5-year prospective study. Rheumatology (Oxford). 2004;43:1039-44.
57. Swaak AJ, Nossent JC, Bronsveld W, et al. Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheu Dis.1989;48:447-54.
58. Goulet JR, MacKenzie T, Levinton C, et al. The longterm prognosis of lupus nephritis: the impact of disease activity. J Rheumatol. 1993;20:59-65.
59. Nived O, Jönsen A, Bengtsson AA, et al. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J Rheumatol. 2002;29:1398-400.
60. Gladman DD, Goldsmith CH, Urowitz MB, et al. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol. 2000;27:373-6.
61. Voss A, Green A, Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand J Rheumatol. 1998;27:98-105.
62. Fortin PR, Abrahamowicz M, Neville C, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus. 1998;7:101-7.
63. Rahman P, Gladman DD, Urowitz MB, et al. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 2001;10:93-6.
64. Stoll T, Seifert B, Isenberg DA. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol. 1996;35:248-54.
65. Kim WU, Min JK, Lee SH, et al. Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol. 1999;17:539-45.
66. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Balt). 1999;78:167-75.
67. Cervera R, Khamashta MA, Font J, et al; European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Balt). 2003;82:299-308.
68. Halberg P, Alsbjørn B, Balslev JT, et al. Systemic lupus erythematosus. Follow-up study of 148 patients. II: Predictive factors of importance for course and outcome. Clin Rheumatol. 1987;6:22-6.
69. Hernández-Cruz B, Tapia N, Villa-Romero AR. Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin Exp Rheumatol. 2001;19:395-401.
70. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum. 1995;38:1492-9.
71. Seleznick MJ, Fries JF. Variables associated with decreased survival in systemic lupus erythematosus. Semin Arthritis Rheum. 1991;21;73-80.
72. Tisseverasinghe A, Lim S, Greenwood C, et al. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2211-9.
73. Ward MM. Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality. J Rheumatol. 2000;27:1408-13.
74. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Balt). 1989;68:141-50.
75. Chen YE, Korbet SM, Katz RS,et al; Collaborative Study Group. Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol. 2008;3:46-53.
76. Bansal VK, Beto JA. Treatment of lupus nephritis: A metaanalysis of clinical trials. Am J Kidney Dis.1997;29:193-9.
77. Ruiz-Irastorza G, Egurbide MV, Pijoan JI, et al. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus. 2006;15:577-83.
78. Alarcón GS, McGwin G, Bertoli AM, LUMINA Study Group. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis. 2007;66:1168-72.
79. Walsh SJ, Gilchrist A. Geographical clustering of mortality from systemic lupus erythematosus in the United States: contributions of poverty, Hispanic ethnicity and solar radiation. Lupus. 2006;15:662-70.
80. Grant WB. Solar UV-B radiation is linked to the geographic variation of mortality from systemic lupus erythematosus in the United States. Lupus. 2004;13:281-2.
81. Ward MM. Hospital experience and mortality in patients with systemic lupus erythematosus. Arthritis Rheum. 1999;42:891-8.
82. Ward MM. Association between physician volume and inhospital mortality in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52;1646-54.
83. Ward MM, Pajevic S, Dreyfuss J, et al. Short term prediction of mortality in patients with systemic lupus erythematosus: Classification of outcomes using random forests. Arthritis Rheum. 2006;55:74-80.
84. Edwards CJ, Lian TY, Badsha H, et al. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome. Lupus. 2003;12:672-6.
85. Williams FM, Chinn S, Hughes GR, et al. Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis. 2002;61:414-21.
86. Alzeer AH, Al-Arfaj A, Basha SJ, et al. Outcome of patients with systemic lupus erythematosus in intensive care unit. Lupus. 2004;13:537-42.
87. Hsu CL, Chen KY, Yeh PS, et al. Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: a retrospective study. Crit Care. 2005;9:177-83.
88. Ansell SM, Bedhesi S, Ruff B, et al. Study of critically ill patients with systemic lupus erythematosus. Crit Care Med. 1996;24:981-4.
89. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum. 2005;52:4003-10.
90. Drenkard C, Villa AR, Garcia-Padilla C, et al. Remission of systematic lupus erythematosus. Medicine (Balt). 1996;75:88-98.